D-Pharm Receives Agreement Letter On Special Protocol Assessment For DP-b99 Study – A Pivotal Phase III Trial In Acute …
April 20, 2010 by biotechcheck.com · Leave a Comment
D-Pharm Receives Agreement Letter On Special Protocol Assessment For DP-b99 Study – A Pivotal Phase III Trial In Acute …
D-Pharm Ltd (DPRM: TASE) announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) procedure for a pivotal phase 3 trial (MACSI) of its neuroprotective agent DP-b99 in acute ischemic stroke patients. The SPA agreement letter indicates that “the design and planned analysis of the study adequately address the objectives …
Read more on Medical News Today
Genocea Biosciences Enters Into Cooperative Research and Development Agreement with U.S. Military to Develop Malaria …
April 17, 2010 by biotechcheck.com · Leave a Comment
Genocea Biosciences Enters Into Cooperative Research and Development Agreement with U.S. Military to Develop Malaria …
CAMBRIDGE, Mass.—-Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has entered into a Cooperative Research and Development Agreement with the Naval Medical Research Center .
Read more on Business Wire via Yahoo! Finance
Southern Research and Vivo Biosciences Announce Collaborative Co-marketing Agreement
April 16, 2010 by biotechcheck.com · Leave a Comment
Southern Research and Vivo Biosciences Announce Collaborative Co-marketing Agreement
Birmingham CRO, biotech company find a way to enhance client offerings through scientific collaboration
Read more on PR Newswire via Yahoo! News
